bpc 157 werking Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157 | Reviews, Clinical Trials,
Description
REDEFINE Trial Headlines Trial REDEFINE 1 Phase 3 Duration 68 weeks Population (N) 3,417 adults with obesity or overweight + 1 comorbidity, without T2D Key Result 20.4% mean weight change vs 3.0% placebo (treatment-policy)
Individuals requiring Vitamin B12 supplementation via intravenous nutrition or nutritional support programs, when indicated
10.1038/aps.2017.12 163 LuoL.GongJ.WangZ.LiuY.CaoJ.QinJ.et al (2022)
And so I was like, okay, well, that seems sort of the point here
